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Intact cholesterol homeostasis helps to maintain
hematopoietic stem and multipotential progenitor
cell (HSPC) quiescence. Mice with defects in choles-
terol efflux pathways due to deficiencies of the ATP
binding cassette transporters ABCA1 and ABCG1
displayed a dramatic increase in HSPC mobilization
and extramedullary hematopoiesis. Increased ex-
tramedullary hematopoiesis was associated with
elevated serum levels of G-CSF due to generation
of IL-23 by splenic macrophages and dendritic cells.
This favored hematopoietic lineage decisions toward
granulocytes rather than macrophages in the bone
marrow leading to impaired support for osteoblasts
and decreased Cxcl12/SDF-1 production by mesen-
chymal progenitors. Greater HSPC mobilization and
extramedullary hematopoiesis were reversed by
raisingHDL levels inAbca1/Abcg1/ andApoe/
mice or in a mouse model of myeloproliferative
neoplasm mediated by Flt3-ITD mutation. Our data
identify a role of cholesterol efflux pathways in the
control of HSPC mobilization. This may translate
into therapeutic strategies for atherosclerosis and
hematologic malignancies.
INTRODUCTION
Hematopoietic stem and multipotential progenitor cells (HSPCs)
reside in specialized environments called stem cell niches in the
medulla of the bone. Whereas the endosteal ‘‘osteoblastic
niche’’ (composed of a subset of specialized osteoblasts in the
inner surface of the bone cavity) is believed to maintain HSPCs
in a quiescent state in poorly perfused regions, the ‘‘vascular
niche’’ (adjacent to the bone marrow [BM] vasculature) may
serve as a transit pathway that senses environmental signalsCand shuttles HSPCs out of the BM (Kiel et al., 2007; Lymperi
et al., 2010; Ehninger and Trumpp, 2011).
In hematologic malignancies such as leukemias and myelo-
proliferative neoplasms, the spleen and the liver resume their
fetal hematopoietic functions causing organomegaly in a pro-
cess called extramedullary hematopoiesis (Kraus et al., 1998;
O’Malley et al., 2005). Symptomatic splenomegaly is common
and causes significant morbidity in these patients. An enlarged
spleen can cause pain, early satiety, pancytopenia, portal hyper-
tension, and hypercatabolic changes. Although not fully under-
stood, extramedullary hematopoiesis is believed to result from
conditions that disrupt the BM microenvironment, facilitating
the egress of progenitor and precursor cells. Mobilization of
hematopoietic stem andmultipotential progenitor cells (HSPCs),
mainly to the spleen, may provide a more permissive microenvi-
ronment for proliferation and myeloid differentiation (Morrison
et al., 1997). Deregulation of this system contributes to the pro-
gression of myeloproliferative diseases (Perry and Li, 2007;
Raaijmakers et al., 2010).
ABCA1 and ABCG1 play an important role in cholesterol
homeostasis by promoting cellular cholesterol efflux to lipid-
poor apoA-I and HDL particles, respectively (Wang et al., 2007;
Yvan-Charvet et al., 2007). Intrinsic deficiency of these trans-
porters in HSPCs led to expansion and proliferation of HSPCs
in BM (Wang et al., 2007; Yvan-Charvet et al., 2007, 2010).
However, this mechanism did not explain splenomegaly and
myeloid cell infiltration of different organs observed in Abca1/
Abcg1/ mice. An investigation of these processes led to the
discovery of dramatic HSPC mobilization in Abca1/Abcg1/
mice reflecting increased G-CSF production. Prior studies have
identified a feedback loop controlling G-CSF and neutrophil
production (Stark et al., 2005).Whenmacrophages phagocytose
apoptotic neutrophils, there is suppression of production of the
cytokine IL-23 leading to decreased G-CSF and neutrophil pro-
duction. Our studies show that the production of IL-23 was
increased in macrophages and dendritic cells deficient in
ABCA1 and ABCG1 and that the resulting increase in G-CSF
led to changes in the bone marrow milieu favoring release of
HSPCs into the circulation.ell Stem Cell 11, 195–206, August 3, 2012 ª2012 Elsevier Inc. 195
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Figure 1. Extramedullary Hematopoiesis in
Abca1–/–Abcg1–/– Mice
Quantification of hematopoietic stem and multi-
potential progenitor cells (HSPCs) by flow cyto-
metry (LSK, LinSca1+c-Kit+) or common myeloid
progenitors (CMP) and granulocye/macrophage
progenitors (GMP) from (A) the blood, (C) the
spleen, or (E) the liver of chow fed WT and
Abca1/Abcg1/ mice. Also displays are
colony-forming unit assays of multipotential pro-
genitors and granulocyte macrophage progenitors
(CFU-GEMM and CFU-GM, respectively) from (B)
the blood, (D) the spleen, or (F) the liver of chow fed
WT and Abca1/Abcg1/ mice. Results are ±
SEMof six animals per group. *p < 0.05 versusWT.
Cell Stem Cell
ABCA1, ABCG1, and HDL Regulate HSPC MobilizationRESULTS
Enhanced HSPC Mobilization and Extramedullary
Hematopoiesis in Abca1–/–Abcg1–/– Mice
Flow cytometry analysis of HSPC, common myeloid progenitors
(CMP) and granulocyte macrophage progenitors (GMP), and
colony forming unit assays of multipotential progenitors (CFU-
GEMM) and GMP (CFU-GM) revealed a 3-fold increase in the
number of these cells in the blood of chow-fed Abca1/
Abcg1/ mice (Figures 1A and 1B; Figure S1A available online)
indicating enhanced HSPC, CMP, and GMPmobilization. Circu-
lating LSK Flk2 cells and LSK CD34 cells were also propor-
tionally increased in these mice (Figure S1B). This was associ-
ated with a parallel 3-fold increase in the number of HSPCs,
CMP, and GMP progenitors and CFU-GEMM/GM in the spleen
(Figures 1C, 1D, and S1D) and liver (Figures 1E, 1F, and S1E)
and increased CFUs in lung and heart cell extracts (Figure S1C).
These changes indicate HSPC mobilization and extramedullary
hematopoiesis in multiple organs in Abca1/Abcg1/ mice.
BM-Dependent Regulation of HSPC Mobilization
in Abca1–/–Abcg1–/– Mice
Transplantation of Abca1/Abcg1/ BM into lethally irradiated
WT recipients showed a 2-fold increase in the number of CFU
in the blood of these mice while reconstitution of Abca1/
Abcg1/ mice with WT BM reduced the number of CFU by
40% (Figure 2A). Analysis of the number of HSPCs in the spleen196 Cell Stem Cell 11, 195–206, August 3, 2012 ª2012 Elsevier Inc.by flow cytometry showed parallel
changes (Figure S2A). Consistent with
our earlier findings, we observed that
the increased number of BM LSK cells re-
flected a BM-dependent role of ABCA1
and ABCG1 and correlated with the cell
surface expression of the IL-3Rb on
HSPCs (Figures S2B and S2C; Yvan-
Charvet et al., 2010). Surprisingly, in
a competitive BM transplantation experi-
ment with equally mixed BM cells from
CD45.1 WT mice and either CD45.2 WT
BM or CD45.2 Abca1/Abcg1/ BM,
we found that the mobilization of
CD45.1 WT HSPCs was increased 2-
fold in presence of CD45.2 Abca1/Abcg1/ BM cells, similar to the effect on CD45.2 Abca1/
Abcg1/ HSPCs, suggesting that the enhanced HSPC mobili-
zation in these mice involved a cell-extrinsic factor (Figure 2B).
This was consistent with the lack of alteration in the cell-surface
expression of key cytokine receptors involved in the migratory
response of HSPCs in Abca1/Abcg1/ mice including the in-
tegrin a4b1 receptor (VLA4), the glycoprotein CD44, the stem cell
growth factor receptor c-kit, and angiopoietin receptor Tie2 (Fig-
ure S2D). Cell-surface expression of CD47 in BM and peripheral
HSPCs, used by these cells to hide from normal scavenging by
myeloid cells (Jaiswal et al., 2009), was also unaltered in
Abca1/Abcg1/ mice (Figure S2E). In addition, analysis of
the circadian oscillation of the number of CFU showed that the
appearance of HSPCs in the blood during the early phase of
the diurnal cycle was increased 2.7-fold in WT recipients trans-
planted with Abca1/Abcg1/ BM compared to 1.7-fold in
controls (Figure S2F). This pattern suggested that the appear-
ance of HSPCs rather than their clearance from the blood was
increased in these mice. Thus, in contrast to the cell-autono-
mous effect of these transporters on HSPC proliferation (Yvan-
Charvet et al., 2010), HSPC mobilization in Abca1/Abcg1/
mice was mediated by cell-extrinsic factors.
G-CSF Dependence of HSPC Mobilization in
Abca1–/–Abcg1–/– BM-Transplanted Mice
We next tested the roles of IL-3, CXCL2 (or macrophage inflam-
matory protein, MIP2), and G-CSF, factors that were previously
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Figure 2. G-CSF-Dependence of HSPC
Mobilization in Abca1–/–Abcg1–/– Mice
Colony-forming unit numbers of multipotential
progenitors (CFU-GEMM) from the blood of WT
and Abca1/Abcg1/ recipient mice trans-
planted with either WT or Abca1/Abcg1/ BM
8 weeks postreconstitution (A). Competitive BM
transplantation of WT CD45.1+ BM was equally
mixed with either CD45.2+ WT BM or CD45.2+
DKO BM and transplanted into WT recipient mice.
Circulating HSPCs were analyzed by flow cy-
tometry (B). WT recipients transplanted with WT
and DKO BM 14 weeks postreconstitution were
i.p. injected with IgG control, 100 mg IL3Rb
blocking antibody, MIP2 (CXCL2) neutralizing
antibody, or G-CSF neutralizing antibody for 16 hr
and analyzed for circulating HSPCs (C). Plasma G-
CSF levels in WT and Abca1/Abcg1/ recipient
mice transplanted with either WT or Abca1/
Abcg1/ BM 8 weeks postreconstitution are
shown (D). Results are ± SEM of five or six animals
per group. *p < 0.05 versus WT recipients trans-
planted with WT BM. #p < 0.05 versus IgG control.
xp < 0.05 versus Abca1/Abcg1/ recipients
transplanted with Abca1/Abcg1/ BM.
Cell Stem Cell
ABCA1, ABCG1, and HDL Regulate HSPC Mobilizationshown to be increased in Abca1/Abcg1/ mice (Yvan-
Charvet et al., 2007, 2008) and also known to have key roles in
the regulation of HSPC mobilization (Guillaume et al., 1993;
Fibbe et al., 1999; Metcalf, 2008; Greenbaum and Link, 2011).
Although injection of IL-3Rb or CXCL2 blocking antibodies did
not prevent the enhanced HSPC mobilization of WT recipients
transplanted with Abca1/Abcg1/ BM, the G-CSF neutral-
izing antibody caused a major reduction in the mobilization of
HSPCs in these mice (Figure 2C) and in the number of HSPCs
in the spleen (data not shown). Alteration in the expression
of the G-CSF receptor was unlikely to explain these effects
because there was no significant change in its cell-surface
expression or mRNA level in different BM populations of
Abca1/Abcg1/ mice (Figures S3A–S3C). Consistent with
a lack of expression of G-CSF receptor on HSPCs (Liu et al.,
2000), addition of G-CSF to in vitro BM cultures did not promote
expansion of either WT or Abca1/Abcg1/ HSPCs (Fig-
ure S3D), and the G-CSF neutralizing antibody did not modulate
the number of BM HSPC in these mice (Figure S3E). The
increased plasma G-CSF in Abca1/Abcg1/ mice was a
BM-mediated effect (Figure 2D). Thus, the absence of ABCA1
and ABCG1 in myeloid BM-derived cells led to an increase in
plasma G-CSF that in turn caused increased mobilization of
HSPCs.
Increased IL-23/IL-17 Drives G-CSF-Dependent HSPC
Mobilization in Abca1–/–Abcg1–/– BM-Transplanted Mice
Consistent with the central role of interleukin-17 (IL-17) as
a potent inducer of G-CSF (Fossiez et al., 1996), we found
increased plasma IL-17 levels in Abca1/Abcg1/ BM-trans-
plantedmice (Figure 3A).We also showed that the administration
of an IL-17 blocking antibody was able to normalize both plasma
G-CSF levels (Figure 3B) and CFU numbers (Figure 3C) in
WT recipients transplanted with Abca1/Abcg1/ BM. The
production of IL-17 can be mediated by commensal bacteria
from the intestinal flora (Ivanov et al., 2008) or by the secretionCof interleukin-23 (IL-23) from splenic phagocytic cells (Stark
et al., 2005). Despite hypertrophy of intestinal Peyer’s patches
in Abca1/Abcg1/ mice (Yvan-Charvet et al., 2010), treat-
ment of these mice with broad spectrum antibiotics including
vancomycin (Yvan-Charvet et al., 2010) to suppress segmented
filament bacteria involved in the induction of intestinal Th17
(Ivanov et al., 2008) did not reduce their plasma IL-17 or
G-CSF levels (Figures 3D and S3F). In contrast, we found
a 4-fold increase in IL-23 concentration in the spleen of these
mice, an effect that was dependent on the absence of ABCA1
and ABCG1 in BM-derived myeloid cells (Figure 3E). Treatment
with an IL-23R neutralizing antibody reduced both plasma
IL-17 and G-CSF levels in WT recipients transplanted with
Abca1/Abcg1/ BM (Figures 3F and S3G) and also the
number of CFU in the blood (Figure S3H).
ABCA1 and ABCG1 Deficiency in Macrophages and
Dendritic Cells Promotes HSPC Mobilization
Because IL-23 is secreted by phagocytic macrophages and
dendritic cells (Stark et al., 2005), we generated macrophage-
specific ABCA1/ABCGG1 knockouts (LysM-cre Abca1fl/fl
Abcg1fl/fl) and dendritic cell-specific ABCA1/ABCG1 knockouts
(CD11c-cre Abca1fl/flAbcg1fl/fl) to examine the contribution of
these cells to HSPC mobilization. LysM-cre Abca1fl/flAbcg1fl/fl
and CD11c-cre Abca1fl/flAbcg1fl/fl mice showed >95% re-
ductions in ABCA1/ABCG1 expression in macrophages and
dendritic cells, respectively, and no difference in ABCA1/
ABCG1 expression in HSPCs (data not shown). We observed
that LysM-cre Abca1fl/flAbcg1fl/fl and CD11c-cre Abca1fl/fl
Abcg1fl/fl mice exhibited a 1.5-fold and 1.8-fold increase in
IL-23 content in their spleen compared to their respective
controls (Figure 4A), with a parallel increase in the number of
CFU in the blood (Figure 4B). This was also associated with an
increase in plasma IL-17 (Figure 4C) and G-CSF (Figure 4D)
levels. In vitro experiments showed that IL-23 mRNA levels
were increased in LysM-cre Abca1fl/flAbcg1fl/fl macrophagesell Stem Cell 11, 195–206, August 3, 2012 ª2012 Elsevier Inc. 197
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Figure 3. IL-23/IL-17-Dependent G-CSF Regulation in Abca1–/–Abcg1–/– Mice
Plasma IL-17 levels in WT and Abca1/Abcg1/ recipient mice transplanted with either WT or Abca1/Abcg1/ BM 8 weeks postreconstitution (A). Plasma
G-CSF levels in WT recipients transplanted with WT and Abca1/Abcg1/ BM 14 weeks postreconstitution and i.p. injected with IgG control or 250 mg IL-17
neutralizing antibody for 16 hr are shown (B). Colony-forming unit numbers from the blood of these mice are displayed in (C). Plasma IL-17 levels in WT and
Abca1/Abcg1/mice treated with broad-spectrum antibiotics for 2 weeks to deplete commensal bacteria are shown in (D). IL-23 protein content in the spleen
of WT and Abca1/Abcg1/ recipient mice transplanted with either WT or Abca1/Abcg1/ BM 8 weeks postreconstitution is shown in (E). Plasma IL-17
levels in WT recipients transplanted with WT and Abca1/Abcg1/ BM 14 weeks postreconstitution and i.p. injected with IgG control or 200 mg IL-23R
neutralizing antibody for 16 hr are illustrated in (F). Results are ±SEMof five or six animals per group. *p < 0.05 versusWT recipients transplantedwithWTBM. #p <
0.05 versus IgG control. xp < 0.05 versus Abca1/Abcg1/ recipients transplanted with Abca1/Abcg1/ BM.
Cell Stem Cell
ABCA1, ABCG1, and HDL Regulate HSPC Mobilizationand CD11c-cre Abca1fl/flAbcg1fl/fl dendritic cells under steady
state or LPS- and poly(I:C)-stimulated conditions (Figure 4E). In
addition, plasma membrane cholesterol depletion by cyclodex-
trin significantly reduced the mRNA expression levels of IL-23
in LysM-cre Abca1fl/flAbcg1fl/fl macrophages under steady state
or LPS- and poly(I:C)-stimulated conditions (Figure 4E) and
completely reversed the increase in CD11c-cre Abca1fl/fl
Abcg1fl/fl dendritic cells (Figure 4F). Thus, in addition to its
known role in promoting granulopoiesis (Stark et al., 2005),
IL-23/IL-17/G-CSF signaling is now shown to be associated
with enhanced HSPC mobilization. Cholesterol efflux pathways
in macrophages and dendritic cells suppressed this signaling
pathway.
IncreasedproteolyticcleavageofCXCR4 inAbca1/Abcg1/
HSPCs is not sufficient to promote their mobilization. These
experiments have been described in the Supplemental Experi-
mental Procedures available online.198 Cell Stem Cell 11, 195–206, August 3, 2012 ª2012 Elsevier Inc.DecreasedCxcl12 Expression in BMofAbca1–/–Abcg1–/–
Mice due to Decreased Expression in Osteoblasts and
Nestin+ Progenitors
These observations suggested that an alternative pathway was
involved in the enhanced HSPC mobilization of Abca1/
Abcg1/ mice. Recent evidence suggests that G-CSF may
decrease Cxcl12/SDF-1 expression (Semerad et al., 2005).
Cxcl12/SDF-1 was reduced by 25% in BM fluid of WT recipients
transplanted with Abca1/Abcg1/ BM, with or without
CXCR4 lentiviral overexpression (Figure S4J). There was a
50% decrease in Cxcl12/SDF-1 mRNA expression and protein
content in the BM (Figure S5A). As the number of dipeptidyl
peptidase-4 (CD26/DPPIV)-positive cells measured by flow
cytometry was reduced by 60% in Abca1/Abcg1/ BM
(Figure S5B), this suggested that the altered production
rather than the cleavage of Cxcl12/SDF-1 was impaired in
these mice. Consistent with this observation, the number of
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Figure 4. Deficiency of ABCA1 and ABCG1 in Macrophages and Dendritic Cells Promotes the G-CSF-Dependent HSPC Mobilization
Splenic IL-23 protein content (A), colony-forming unit numbers (B), plasma G-CSF levels (C), and plasma IL-17 levels (D) in 28-week-old Abca1fl/flAbcg1fl/fl
(controls), LysM-Cre Abca1fl/flAbcg1fl/fl, and CD11c-Cre Abca1fl/flAbcg1fl/fl mice. Results are ± SEM of five or six animals per group. *p < 0.05 versus controls.
Modulation of IL-23 mRNA expression levels in Abca1fl/flAbcg1fl/fl and LysM-Cre Abca1flflAbcg1fl/fl BM-derived macrophages (E) and CD11c-Cre Abca1fl/fl
Abcg1fl/fl BM-derived dendritic cells (F) are shown after manipulation of plasma membrane cholesterol. Cells were incubated with 5 mmol/l cyclodextrin (CD) for
30min before treatment with 50 ng/ml lipopolysaccharide (LPS, TLR4 ligand) or 2.5 mg/ml PolyI:C (TLR3 ligand) for 3 hr. IL-23 transcript levels were normalized to
m36B4mRNA amount. RNA levels were expressed as arbitrary units (a.u.). Values aremean ± SEMof an experiment performed in quadruplicate. *p < 0.05 versus
respective controls. xp < 0.05 versus conditions without cyclodextrin treatment.
Cell Stem Cell
ABCA1, ABCG1, and HDL Regulate HSPC MobilizationSDF-1-expressing reticular (CAR) cells (Sugiyama et al., 2006)
but not non-SDF-1-expressing cells was reduced in Abca1/
Abcg1/ BM (Figure S5C). Together these findings suggested
that the enhanced HSPC mobilization of Abca1/Abcg1/
BM-transplanted mice could not be attributed to increased
neutrophil elastase 2-dependent CXCR4 cleavage but rather re-
flected reduced SDF-1/Cxcl12 mRNA expression. In addition,
we found that the 50% decrease in SDF-1/Cxcl12 BM fluid
content was mainly attributable to the lack of ABCA1 and
ABCG1 in BM-derived myeloid cells (Figure 5A). Endothelial
cells, osteoblasts (OBs), and Nestin+ mesenchymal stem cellsC(MSCs) were reported to be the major Cxcl12/SDF-1-expressing
cell types within the BM (Dar et al., 2005; Semerad et al., 2005;
Christopher et al., 2009; Me´ndez-Ferrer et al., 2010). To gain
more insight into the regulation of Cxcl12/SDF-1 in Abca1/
Abcg1/mice, we bred thesemice with mice expressing yellow
fluorescent protein (YFP) under the control of regulatory
elements of the nestin promoter to allow the identification of
Nestin+ MSCs. We compared the mRNA expression levels of
Cxcl12/SDF-1 in sorted CD45-Ter119Nestin+ MSCs, Lin
CD45CD31Sca-1CD51+ OB lineage cells, and LinCD45
CD31+ endothelial cells (Figure S5D). High osteocalcin andell Stem Cell 11, 195–206, August 3, 2012 ª2012 Elsevier Inc. 199
A0,0
0,2
0,4
0,6
WT recipient DKO recipient
S
D
F
-
1
/C
x
c
l1
2
 
B
M
 
f
lu
id
(
n
g
/m
g
 p
r
o
t
e
in
)
WT BMT
DKO BMT
*
*
0
20
40
60
80
Lin
-
CD31
+
(ECs)
Lin
-
CD31
-
CD51
+
(OBs)
Lin
-
Nestin
EYFP
(MSCs)
S
D
F
-
1
/
C
x
c
l
1
2
 m
R
N
A
 
(
a
.
u
)
WT BM
DKO BM
*
*
B
0
20
40
60
80
100
120
Collagen
Crosslink
ratio
Crystallinity
B
o
n
e
 
h
e
t
e
r
o
g
e
n
e
i
t
y
 
(
%
)
Mineral/Matrix
ratio
Carbonate/
Phosphate
Ratio
*
* *
WT
Abca1
-/-
Abcg1
-/-
F
W
H
M
C
0 10
2
10
3
10
4
10
5
Lin
Abca1
-/-
Abcg1
-/-
0 10
2
10
3
10
4
10
5
0
10
2
10
3
10
4
10
5
Lin
N
e
s
t
in
-
E
Y
F
P
Wild-type
Lin-
Nestin+ Nestin+
010
2
10
3
10
4
10
5
Sca-1
Abca1
-/-
Abcg1
-/-
Wild-type
010
2
10
3
10
4
10
5
Sca-1
0
10
3
10
4
10
5
C
D
5
1
10
2
Lin- CD45-CD31-
OBs OBs
0 10
3
10
4
10
5
0
10
3
10
4
10
5
N-Cadherin
C
D
5
1
10
2
10
2
Lin- CD45-CD31-
Wild-type
0 10
3
10
4
10
5
N-Cadherin
10
2
Abca1
-/-
Abcg1
-/-
N-Cad+
OBs
N-Cad+
OBs
D
0,00
0,02
0,04
0,06
0,08
C
e
ll
 
p
o
p
u
la
t
io
n
 
(
%
 
B
M
) WT
DKO
Lin
-
Nestin
EYFP+
(MSCs)
*
Lin
-
CD51
+
(OBs)
*
Lin
-
CD51
+
N-Cad
+
(N-Cad
+
OBs)
Figure 5. Reduced Osteoblastic SDF-1/Cxcl12 Production in Abca1–/–Abcg1–/– Mice
Quantification of the SDF-1/Cxcl12 protein content in the BMfluid ofWT andAbca1/Abcg1/ recipientmice transplantedwith eitherWTorAbca1/Abcg1/
BM 8 weeks postreconstitution (A). SDF-1/Cxcl12 mRNA levels normalized to ribosomal m36B4 in sorted LinCD45CD31+ endothelial cells (ECs),
LinCD45CD31Sca1CD51+ OB lineage cells (OBs), and Lin-Nestin+ progenitors (MSCs) from Nestin-Cre+Gt(Rosa)26Sor and Abca1/Abcg1/ Nestin-
Cre+Gt(Rosa)26Sor mice are shown in (B). Representative histograms and percentage changes in the bone heterogeneity of the indicated bonemineral andmatrix
properties quantified by Fourier Transform Infrared (FTIR) spectroscopy as the full width at half maximum (FWHM) of the pixel histogram distribution (PHD) are
shown in (C). Representative dot plots and quantification of Lin-Nestin+MSCs, LinCD45CD31Sca1CD51+ OB lineage cells, and LinCD45CD31CD51+N-
Cadherin+ OBs by flow cytometry are displayed in (D). Results are ±SEMof five or six animals per group. *p < 0.05 versusWT. xp< 0.05 versusAbca1/Abcg1/
recipients transplanted with Abca1/Abcg1/ BM.
Cell Stem Cell
ABCA1, ABCG1, and HDL Regulate HSPC MobilizationVE-cadherin expression confirmed that bone LinCD45
CD31Sca-1CD51+ cells and LinCD45CD31+ cells were en-
riched in OBs and endothelial cells, respectively (Figure S5E). As
previously reported, BM endothelial cells expressed low amount200 Cell Stem Cell 11, 195–206, August 3, 2012 ª2012 Elsevier Inc.of Cxcl12/SDF-1 compared to OBs (Semerad et al., 2005), and
no change was observed between WT and Abca1/Abcg1/
mice (Figure 5B). Although ABCA1 and ABCG1 mRNA ex-
pression were barely detectable in Nestin+ MSCs and OBs
Cell Stem Cell
ABCA1, ABCG1, and HDL Regulate HSPC Mobilization(data not shown), there was a 50% decrease in Cxcl12/SDF-1
expression in Nestin+ MSCs and almost complete absence of
Cxcl12/SDF-1 expression in OBs isolated from Abca1/
Abcg1/ BM compared to controls (Figure 5B). Vascular cell
adhesion molecule-1 (VCAM-1), another HSPC maintenance
gene, was also reduced in these cells (data not shown). Thus,
lack of ABCA1 and ABCG1 indirectly modulates the expression
of the key HSPC maintenance gene Cxcl12/SDF-1 in OBs and
their Nestin+ progenitors.
Reduced Cxcl12/SDF-1 Expression in Abca1–/–Abcg1–/–
BM Is Associated with Decreased N-Cadherin+
Osteoblasts
In addition to reducedCxcl12/SDF-1 expression in OBs and their
Nestin+ progenitors, it has been shown that reduced osteoblast
numbers, especially N-Cadherin+ bone-lining, spindle-shaped
OBs, could contribute to the lack of HSPC retention within the
BM (Zhang et al., 2003; Visnjic et al., 2004; Lymperi et al.,
2008). Bone histomorphometry analysis in Abca1/Abcg1/
mice revealed no significant change in the percentage of bone
cancellous surface occupied by various heterogeneous popula-
tions of OBs including endosteal, trabecular, and periosteal OBs
as well as osteoclasts (Figure S5F). These data were consistent
with similar bone mineral density measured in vivo by DEXA
(Figure S5G). Fourier transform infrared imaging (FTIRI) analysis
of tibial cortical bone also revealed similar mineral/matrix,
carbonate/phosphate and collagen crosslink ratio, as well
as crystallinity between WT and Abca1/Abcg1/ mice (Fig-
ure S5H). Thus, the enhanced HSPC mobilization in Abca1/
Abcg1/ mice was not the consequence of altered mineral or
matrix bone properties. However, a decrease in the heteroge-
neous distribution of bone tissue material properties was noted
for almost all of the measured FTIRI parameters in the bone of
Abca1/Abcg1/ mice (Figure 5C). This reflected reduced
bone remodeling with fewer regions of newly formed bone tissue
(Gourion-Arsiquaud et al., 2010) and suggested some specificity
in osteoblastic lineage fate in these mice. Although the reduced
number of Nestin+ MSCs in Abca1/Abcg1/ BM did not
reach significance (Figure 5D), there was a pronounced 3-fold
decrease in the number of LinCD45CD31Sca-1CD51+ OB
lineage cells (Figure 5D). We also observed similar reductions
in LinCD45CD31CD51+N-Cadherin+ OB population in the
BM of these mice (Figure 5D). Of note, all LinCD45
CD31CD51+Sca-1 OBs were N-Cadherin+ (data not shown).
Thus, the reduced production of SDF-1/Cxcl12 in Abca1/
Abcg1/ BM reflected not only reduced expression of this
HSPC maintenance gene but also decreased numbers of
N-Cadherin+ OB-derived Nestin+ MSCs.
Depletion of BM Macrophages Contributes to Reduced
Cxcl12/SDF-1 Expression in Abca1–/–Abcg1–/– BM
Recent studies have highlighted a role of BM macrophages in
supporting osteoblast differentiation and SDF-1/Cxcl12 pro-
duction (Winkler et al., 2010; Christopher et al., 2011; Chow
et al., 2011). We next examined BM macrophages by flow
cytometry in WT and Abca1/Abcg1/ mice transplanted
with either WT or Abca1/Abcg1/ BM. Two different popula-
tions of macrophages have been described in the BM, namely
CD11bhi osteomacs (Winkler et al., 2010) and CD11bintCD169+Cmacrophages (Chow et al., 2011) that are localized in different
hypoxic area of the BM (Ehninger and Trumpp, 2011). The gating
strategy is provided in Figure S6A. Both populations of macro-
phages were dramatically reduced, by 2- and 4-fold, respec-
tively, in WT recipients transplanted with Abca1/Abcg1/
BM, and this was dependent on a role of ABCA1 and ABCG1
within the BM-derived myeloid population as shown by the fact
that transplantation ofWTBM intoAbca1/Abcg1/ recipients
almost completely reversed this loss (Figures 6A and 6B). Inter-
estingly, the role of G-CSF in mediating HSPC mobilization was
recently shown to involve the G-CSF receptor within cells of the
monocytic lineage (Christopher et al., 2011). Therefore, we next
took advantage of the finding that the IL-17 neutralizing antibody
reduced the plasma G-CSF levels in these mice. Treatment of
WT recipients transplanted with Abca1/Abcg1/ BM with
this antibody largely rescued the loss of both BM macrophage
populations (Figures 6C and 6D) and the reduced SDF-1/
Cxcl12 BM fluid content (Figure S6B). Similar findings were
observed with the use of IL-23R neutralizing antibody (Figures
S6C and S6D) and reduced BM macrophage populations were
also observed in LysM-cre Abca1fl/flAbcg1fl/fl and CD11c-cre
Abca1fl/flAbcg1fl/fl mice (Figure S6E). This revealed that the
enhanced IL-23/IL-17/G-CSF axis contributed substantially to
the depletion of both BM macrophage populations and subse-
quent loss of BM SDF-1/Cxcl12 production. Finally, consistent
with earlier work (Zhu and Emerson, 2002; Rieger et al., 2009),
in vitro BM cultures showed that G-CSF treatment of Abca1/
Abcg1/ BM cultures resulted in increased neutrophil but
decreased monocyte production, whereas IL-3 treatment in-
creased both neutrophils and monocytes, suggesting that
G-CSF instructed hematopoietic progenitor determination to
favor neutrophilic over monocytic lineages (Figures S6F and
S6G). Consistent with these findings, we observed that in vitro
treatment of WT BM cells with 10% serum from Abca1/
Abcg1/ mice favored mainly GMP and to some extent MDP
expansion compared to WT serum (Figures 6E, S6H, and S6I),
leading to a major increase in the number of neutrophils (Fig-
ure 6F). The use of the G-CSF neutralizing antibody in these
cultures revealed that the inhibition of GMP and neutrophil
expansion (Figures 6E and 6F) was associated with a significant
increase in the number of monocytes (Figure 6F), indicating that
G-CSF acted at the level of GMP to tightly control the leukocyte
fate. Thus, we propose that enhanced IL-23/IL-17-dependent
G-CSF production by Abca1/Abcg1/ splenic phagocytic
cells induced HSPC mobilization by altering the fate of GMPs
such that there was decreased formation of monocyte/
macrophage-lineage cells and decreased macrophage-depen-
dent osteoblastic support and SDF-1/Cxcl12 production.
RaisingHDL-Cholesterol SuppressesHSPCMobilization
in Mouse Models of Hypercholesterolemia and
Myeloproliferative Disorders
Expression of the human apoA-I transgene led to reduced
plasma G-CSF (Figure 7A) and reduced HSPC mobilization in
Abca1/Abcg1/ BMT mice (Figure 7B), providing a mecha-
nism to explain the reversal of extramedullary hematopoiesis,
splenomegaly, andmyeloid cell proliferation by the apoA-I trans-
gene. This was associated with reduced splenic mRNA expres-
sion of IL-23 (data not shown). We next tested whether theell Stem Cell 11, 195–206, August 3, 2012 ª2012 Elsevier Inc. 201
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Figure 6. Depletion of BM Macrophages in Abca1–/–Abcg1–/– Mice
Quantification of BMmacrophage subsets by flow cytometry inWT andAbca1/Abcg1/ recipient mice transplanted with either WT orAbca1/Abcg1/BM
8 weeks postreconstitution (A and B) and in WT recipients transplanted with WT and Abca1/Abcg1/ BM 14 weeks postreconstitution and i.p. injected with
IgG control or 250 mg IL-17 neutralizing antibody for 16 hr (C and D). Results are ± SEM of five or six animals per group. *p < 0.05 versus WT. xp < 0.05 versus
Abca1/Abcg1/ recipients transplanted with Abca1/Abcg1/ BM. Quantification of hematopoietic progenitors (E), monocytes, and neutrophils (F) in WT
BM cultures grown for 48 hr in liquid culture in presence of 10% of the indicated serum and 50 ng/mL G-CSF neutralizing antibody (+) or control non-specific IgG
() are shown. Results are ± SEM of three independent experiments. #p < 0.05 versus IgG control. yp < 0.05 versus 10% WT serum.
Cell Stem Cell
ABCA1, ABCG1, and HDL Regulate HSPC Mobilizationsuppression of HSPC mobilization by raising HDL levels in
Abca1/Abcg1/ BM-transplanted mice was peculiar to this
model or could be observed as a more general phenomenon in
other mouse models of hypercholesterolemia or MPN. We
recently reported that hypercholesterolemic Apoe/ mice ex-
hibited a similar phenotype to Abca1/Abcg1/ mice and
that infusion of rHDL suppressed their leukocytosis (Murphy
et al., 2011). Apoe/ mice fed a high fat diet for 4 weeks ex-
hibited a 2-fold increased plasma G-CSF levels (Figure 7C) that
correlated with their number of circulating HSPCs (Figure 7D).
Infusion of 80 mg/kg rHDL reduced by approximately 40% not
only the plasma G-CSF levels (Figure 7C) but also the number
of circulating HSPCs in thesemice 96 hr postinfusion (Figure 7D).
Finally, we transplanted BM transducedwith retroviruses encod-
ing Flt3-ITD, an oncogenicmutation previously identified in acute
myeloid leukemia (AML) that confers a fully penetrant myelopro-
liferative disorder in mice (Kelly et al., 2002) into either WT or
apoA-I transgenic mice. Reduced plasma HDL-cholesterol
levels have been previously reported in myeloproliferative disor-202 Cell Stem Cell 11, 195–206, August 3, 2012 ª2012 Elsevier Inc.ders (Gilbert et al., 1981; Dessı` et al., 1995). Consistent with
these reports, mice bearing the Flt3-ITD mutation exhibited
a 1.5-fold decrease in their plasma HDL-cholesterol levels (Fig-
ure S7A) and this was associated with reduced mRNA expres-
sion levels of ABCA1 but not ABCG1 in their spleen (Figure S7B).
Remarkably, there was a 4-fold increase in plasma G-CSF levels
and circulating HSPC numbers in mice bearing the Flt3-ITD
mutation, and both parameters were markedly reduced by the
human apoA-I transgene (Figures 7E and 7F). This was associ-
ated with reducedmRNA expression of IL-23 in their spleen (Fig-
ure S7C), reduced plasma IL-17 (Figure S7D), and suppression
of splenomegaly (Figure S7E) and splenic HSPC infiltration (Fig-
ure S7F). Finally, the depletion of HSPCs in the BM of mice
bearing the Flt3-ITD mutation was prevented by overexpression
of the apoA-I transgene (Figure S7G), reflecting increasedmRNA
expression levels of SDF-1/Cxcl12 (Figure S7H). Thus, similar
mechanisms of HSPC mobilization and reversal by increased
HDL levels appear to be involved in both the Abca1/Abcg1/
and the Flt3-ITD models of MPNs.
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Figure 7. Raising HDL-Cholesterol Prevents HSPC Mobilization
Plasma G-CSF levels and quantification of circulating HSPCs by flow cytometry in WT and ApoA-I transgenic recipient mice transplanted with either WT or
Abca1/Abcg1/ BM 12 weeks postreconstitution (A and B), in 4-week-old, high fat diet-fedWT and apoE/mice infused or not with 80 mg/kg rHDL for 96 hr
(C and D), and in WT and ApoA-I transgenic recipient mice transplanted with BM transduced with retroviruses encoding the human oncogenic Flt3-ITD mutation
6weeks postreconstitution (E and F) are shown. Results are ± SEMof four to six animals per group. *p < 0.05 versusWT. xp < 0.05, effect of HDL-raising treatment
(hapoA-ITg or rHDL).
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ABCA1, ABCG1, and HDL Regulate HSPC MobilizationDISCUSSION
Wehave identified a role of cholesterol efflux pathways in limiting
the mobilization of HSPCs and prevention of clinically detri-
mental extramedullary hematopoiesis in mouse models of
myeloproliferative disorders. In mice with knockout of trans-
porters ABCA1 and ABCG1 in all BM cells, or exclusively in
macrophages or dendritic cells, increased IL-23-dependent
production of growth factor G-CSF alters the BM niche leading
to HSPC mobilization and infiltration of distant organs. Concor-
dant with a recent study (Rieger et al., 2009), increased G-CSF
acts via GMPs to direct myeloid production toward neutrophils
rather than monocytes, eventuating in BM macrophage deple-
tion. Consequently, OB populations as well as the production
of SDF-1/Cxcl12 are reduced. Importantly, our findings indicate
a beneficial effect of increased HDL levels in preventing or
reversing HSPCmobilization and extramedullary hematopoiesis,
not only in Abca1/Abcg1/ mice and Apoe/ mice but alsoCin a mouse model of hematological malignancy. These findings
suggest a therapeutic application of rHDL infusion in the preven-
tion of extramedullary hematopoiesis in both atherosclerosis and
hematologic malignancies.
Ley and colleagues have defined a negative feedback loop
controlling granulopoiesis in which uptake of apoptotic neutro-
phils by macrophages and dendritic cells leads to suppression
of IL-23 production, decreased release of IL-17 by lymphocytes,
and decreased production of G-CSF by bone marrow stromal
cells (Stark et al., 2005). Our results provide evidence that acti-
vation of the IL-23/IL-17/G-CSF signaling axis in mice with
defective cholesterol efflux pathways leads to increased
HSPC mobilization. Moreover, by using cell-specific knockouts
of ABCA1 and ABCG1, we show the importance of the choles-
terol efflux pathways in macrophages and dendritic cells in the
control of IL-23 production. This links the control of HSPCmobi-
lization to cholesterol homeostasis in the innate immune
system.ell Stem Cell 11, 195–206, August 3, 2012 ª2012 Elsevier Inc. 203
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ABCA1, ABCG1, and HDL Regulate HSPC MobilizationIn agreement with previous studies (Rieger et al., 2009),
increased plasma G-CSF levels in Abca1/Abcg1/ mice
direct hematopoietic lineages in vitro toward neutrophil rather
than monocyte/macrophage production. This led to an expan-
sion of neutrophils and loss of macrophage populations in the
BM. Neutrophil expansion in Abca1/Abcg1/ mice trans-
formed the BM into a highly proteolytic environment (Le´vesque
et al., 2002) leading to cleavage of CXCR4 by neutrophil elastase
2 (Petit et al., 2002; Levesque et al., 2003). However, this alone
could not explain enhancedHSPCmobilization because deletion
of Elane or lentiviral overexpression of CXCR4 did not rescue this
phenotype. Rather, our studies indicated an essential role
of reduced BM SDF-1/Cxcl12 production in HSPC mobiliza-
tion. This is consistent with the recently demonstrated role of
decreased SDF-1/Cxcl12 in mediating the effect of G-CSF on
HSPC mobilization (Levesque et al., 2004; Semerad et al.,
2005; Christopher and Link, 2008).
While macrophage depletion has been shown to promote
HSPC mobilization by disruption of the osteoblastic niche
through impaired osteoblast (OB) activity and SDF-1/Cxcl12
production (Winkler et al., 2010; Gordy et al., 2011; Chow
et al., 2011; Christopher et al., 2011), the link with endogenous
plasma G-CSF appears to be unexplored. Greater endogenous
plasma G-CSF induced the loss of BMmacrophage populations
in Abca1/Abcg1/ mice leading to decreased SDF-1/Cxcl12
production. This involved decreases in N-Cadherin+ OB subsets
and Nestin+ progenitors. Previous studies have shown that these
cell populations have a key role in maintaining HSPCs in their
niche (Lymperi et al., 2008; Visnjic et al., 2004; Me´ndez-Ferrer
et al., 2010; Raaijmakers et al., 2010). Thus, our study shows
that cholesterol efflux pathways in splenic macrophages and
dendritic cells are linked to control of the osteoblastic niche
and HSPC mobilization via the IL23/IL17/G-CSF signaling axis.
Overexpression of the human apoA-I transgene to raise HDL
levels prevented the myeloproliferative disorders of Abca1/
Abcg1/ BM transplanted mice (Yvan-Charvet et al., 2010).
We now provide evidence that this effect was partly mediated
by reduced plasma G-CSF levels and HSPC mobilization. We
recently showed that Apoe/mice have expanded and prolifer-
ating HSPCs (Murphy et al., 2011). ApoE is expressed on the
surface of HSPCs where it appears to interact with ABCA1 and
ABCG1 to promote cholesterol efflux (Laffitte et al., 2001;
Murphy et al., 2011). Apoe/ mice also develop hepatospleno-
megaly on WTDs likely reflecting extramedullary hematopoiesis
(Murphy et al., 2011). A recent study has shown that the spleen
represents an important reservoir of monocytes in Apoe/
mice, contributing directly to atherosclerotic lesions (Robbins
et al., 2012). Together with our study, this suggests that extrame-
dullary hematopoiesis resulting from increased G-CSF in
Apoe/ mice plays a role in atherogenesis. Moreover, infusion
of cholesterol-poor phospholipid/apoA-I complexes (i.e, rHDL;
Murphy et al., 2011), suppressed plasma G-CSF levels and
HSPC mobilization, uncovering a potential anti-atherogenic
effect of this treatment.
The relevance of the human apoA-I transgene was also tested
in a mouse model of myeloproliferative disorder induced by an
activating mutation in the Flt3 gene (Flt3-ITD), the most common
mutation associated with acute myeloid leukemia (AML) in
humans. Consistent with their myeloproliferative disorder, mice204 Cell Stem Cell 11, 195–206, August 3, 2012 ª2012 Elsevier Inc.that received BM transducedwith retroviruses encoding Flt3-ITD
exhibited splenomegaly (Kelly et al., 2002), and this was associ-
ated with increased splenic expression of IL-23, increased
plasma G-CSF, and HSCmobilization, likely reflecting an under-
lying expansion of DCs by Flt3 signaling (Liu and Nussenzweig,
2010). The MPN was associated with reduced plasma choles-
terol, and raising HDL levels though overexpression of the
human apoA-I transgene partially prevented these defects. Our
findings indicate that HDL-mediated cholesterol efflux pathways
in macrophages and dendritic cells act to suppress HSPCmobi-
lization and extramedullary hematopoiesis, and that HDL raising
treatments could have beneficial effects on these processes in
atherosclerosis and hematological malignancies.
EXPERIMENTAL PROCEDURES
Mice and Treatments
Human apoA-I transgenic (B6.Tg(ApoA1)1Rub/J), Apoe/ (B6.129P2-
Apoetm1Unc), Elane/ (B6.129X1-Elanetm1Sds/J), Nestin-Cre (B6.Cg-Tg(nes-
cre)1kln/J), and RosaEYFP (B6.129x1Gt(Rosa)26Sortm1EYFP/J) mice were obtained
from the Jackson laboratory. Wild-type and Abca1/Abcg1/ littermates in
amixed C57BL/63DBAbackground (Yvan-Charvet et al., 2007) were used for
this study, unless otherwise noted. LysM-Cre Abca1fl/flAbcg1fl/fl mice and
CD11c-Cre Abca1fl/flAbcg1fl/fl mice were obtained by crossing Abca1fl/fl
mice (kindly provided by Dr. Parks, Wake Forest University) and Abcg1fl/fl
mice (generated at Columbia University) with LysM-Cre mice (B6.129P2-
Lyz2tm1(cre)Ifo/J) and CD11c-Cre mice (C57BL/6J-Tg(Itgax-cre,-EGFP)),
respectively, from the Jackson laboratory. Cre efficiency was confirmed by
RT-PCR against the targeted ABCA1 and ABCG1 genes in macrophages
and dendritic cells, respectively (data not shown). Mice were fed either
a regular chow diet or a Western diet (TD 88137, Harlan Teklad) as indicated
in the figure legends. BM transplantation into the genetically uniform F1 gener-
ation obtained by crossing C57BL/6 wild-type or hapoA-1Tg mice with wild-
type DBA mice (The Jackson laboratory) was performed as previously
described (Yvan-Charvet et al., 2007). For neutralizing antibody experiments,
WT and Abca1/Abcg1/ BM transplanted mice were i.p. injected 16 hr
before analysis with the following antibodies: anti-IL-3Rb AF549, anti-Cxcl2
MAB452, anti-IL-23R MAB1686, anti-IL-17 MAB421, and anti-G-CSF
MAB414 (all from R&D Systems). Treatments with rHDL (provided by CSL
Australia) or vehicle (saline) were administered via the tail vein. All mice were
housed at Columbia University Medical Center according to animal welfare
guidelines. Mice were maintained on a 12 hr light/12 hr darkness lighting
schedule. Animals had ad libitum access to both food and water.
Colony-Forming Assay
All experiments were performed between 12:00 and 1:00 p.m. to limit vari-
ability between experiments. For peripheral blood CFU assays, 300 ml of blood
were collected into EDTA tubes before red blood cell lysis, filtration, and centri-
fugation for 5 min at 1,000 rpm. Splenocytes were extracted by pressing
spleens through a stainless steel grid. Single-cell suspension was submitted
to red blood cell lysis, filtration, and centrifugation for 5 min at 1,000 rpm.
For liver, lung, and heart CFU assays, tissues were cut in small piece and
digested with 1 mg/ml collagenase D (Roche) for 30 min at 37C before red
blood cell lysis, filtration, and centrifugation for 5 min at 1,000 rpm. Peripheral
cells, splenocytes (53 104), liver, lung, and heart cells (13 106) were plated in
methylcellulose-based media containing a cocktail of recombinant cytokines
including SCF, IL-3, and IL-6 (Methocult, Stemcell) supplemented with 2%
FCS to generate multipotential progenitor cells (CFU-GEMM) in presence or
absence of 10% IL-3 supplement media (BD Bioscience) and GM-CSF
(2 ng/ml) (Mix conditions) (R&D Systems) to generate granulocyte-macro-
phage progenitors (CFU-GMs). The number of CFUs per dish was scored after
10 days of differentiation.
Flow Cytometry Analysis and Cell Sorting
BM cells, peripheral blood leukocytes, and splenocytes were collected as
described above. Cells were stained with the appropriate antibodies for
Cell Stem Cell
ABCA1, ABCG1, and HDL Regulate HSPC Mobilization30 min on ice. Intracellular stainings were performed using the Cytofix/
Cytoperm kit (BD Biosciences) according to the manufacturer’s protocol.
Endothelial cells, osteoblasts, and Nestin+ cells were isolated at previously
described (Semerad et al., 2005). Briefly, tibias and femurs were flushed
thoroughly of BM cells, chopped with a scalpel, and washed three times to
further remove residual BM cells. The bone fragments were then digested
with collagenase type IA (Sigma-Aldrich) for 30 min at 37C before red blood
cell lysis, filtration, and centrifugation for 5 min at 1,000 rpm. Multiparameter
analyses of stained cell suspensions were performed on a four-laser BD LSRII
cell analyzer or sorted on a BD FACSAria Cell Sorter both running with DiVa
software (BD Biosciences). Viable cells were gated by light scatter or exclusion
of CD45 cells. Data were analyzed using FlowJo software (Tree Star Inc.).
Statistical Analysis
Statistical significance was assessed by performing two-tailed parametric
Student’s t test or one-way analysis of variance (ANOVA, four-group compar-
isons) with a Bonferroni multiple comparison post-test (GraphPad software,
San Diego, CA).SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Results, Supplemental
Experimental Procedures, and seven figures and can be found with this article
online at http://dx.doi.org/10.1016/j.stem.2012.04.024.
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